Table 3.
Prevalence of somatic, psychological and urogenital symptoms and of anxiety/depression and OR (95% CI) for its association with menopausal status
| Somatic symptoms | Psychological symptoms | Urogenital symptoms | Anxiety/depression | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crude | Adjusteda | Crude | Adjusteda | Crude | Adjusteda | Crude | Adjusteda | |||||
| N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | |
| Pre-menopause (N = 44) | 15 (34.1%) | 1 | 1 | 18 (40.9%) | 1 | 1 | 19 (43.2%) | 1 | 1 | 5 (11.4%) | 1 | 1 |
| Peri-menopause (N = 70) | 42 (60.0%) | 2.90 [1.37–6.16] | 3.01 [1.38–6.55] | 38 (54.3%) | 1.72 [0.71–4.16] | 2.18 [0.87–5.40] | 34 (48.6%) | 1.24 [0.65–2.4] | 1.09 [0.57–2.09] | 13 (18.6%) | 1.78 [0.69–4.60] | 2.33 [0.69–7.85] |
| Post-menopause (N = 137) | 80 (58.4%) | 2.71 [1.57–4.69] | 2.63 [1.44–4.81] | 83 (60.6%) | 2.22 [1.21–4.06] | 2.16 [1.13–4.14] | 86 (62.8%) | 2.22 [1.26–3.90] | 2.54 [1.42–4.85] | 30 (21.9%) | 2.19 [0.88–5.41] | 1.66 [0.48–5.67] |
| p value | 0.011 | 0.072 | 0.030 | 0.300 | ||||||||
Bold values are statistically significant
OR: Odds Ratio from logistic regression for the association between menopausal status at the presence of menopausal symptoms in each MRS domain and of anxiety/depression
aAdjusted for mode of transmission, current occupational status, smoking, drug use, social support, current partner